Fournier gangrene future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Fournier gangrene}} {{SCC}}; {{AE}} {{YK}}; {{JH}} ==Overview== ==References== {{Reflist|2}}" |
Category |
||
Line 7: | Line 7: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Surgery]] | |||
[[Category:Orthopedics]] | |||
[[Category:Dermatology]] |
Revision as of 14:38, 21 September 2017
Fournier gangrene Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Fournier gangrene future or investigational therapies On the Web |
American Roentgen Ray Society Images of Fournier gangrene future or investigational therapies |
FDA on Fournier gangrene future or investigational therapies |
Fournier gangrene future or investigational therapies in the news |
Blogs onFournier gangrene future or investigational therapies |
Risk calculators and risk factors for Fournier gangrene future or investigational therapies |
Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]